Skip to main content

Institutional filer profile

ARCH Venture Partners X Overage L.P. Insider Trades

ARCH Venture Partners X Overage L.P. has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $19,960,155 across 2 companies. The most recent open-market transaction was reported on Nov 2, 2026. Source: SEC Form 4 filings.

Latest reported as 10% Owner of Aspen Neuroscience, Inc. (ASPE).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
1
Reported companies
2
Net open-market value
$19,960,155
Latest transaction
Nov 2, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 2, 2026Aspen Neuroscience, Inc. (ASPE)10% OwnerOpen Market Purchase1,333,333$15.00$19,999,995
Jul 1, 2026Boundless Bio, Inc. (BOLD)Corporate insiderSale16,000$2.49$39,840

Common questions

ARCH Venture Partners X Overage L.P. insider trading FAQ

Is ARCH Venture Partners X Overage L.P. buying or selling stock?
Across all SEC Form 4 open-market filings on record, ARCH Venture Partners X Overage L.P. is a net buyer of $19,960,155, with 1 open-market purchase reported. The latest transaction was reported on Nov 2, 2026.
Which companies does ARCH Venture Partners X Overage L.P. report insider trades for?
ARCH Venture Partners X Overage L.P. has reported open-market trades in Aspen Neuroscience, Inc. (ASPE), Boundless Bio, Inc. (BOLD). The latest SEC-reported relationship is 10% Owner of Aspen Neuroscience, Inc. (ASPE).
Where does ARCH Venture Partners X Overage L.P.'s insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under filer CIK 1768905, and refreshes this page daily.